CAR T-cell Therapy in 2022: What You Need to Know Part II

Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX

Everything You Need to Know About Cutaneous T-cell Lymphoma

Francine Foss, MD and John A. Zic, MD, MMHC

A Deep Dive into Myelofibrosis

Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center, Houston, TX

Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part I

Jacqueline C. Barrientos, MD, MS, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY

CAR T-cell Therapy in 2022: What You Need to Know

Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA

Highpoints from Attending the 2021 American Society of Hematology Conference

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY